BIIB Biogen Earnings and EPS analysis

EPS in 2026 (TTM): $9.35

Last Report Period Date: Mar 31, 2026

As of June this year, based on Biogen's most recent financial report, the company's trailing twelve months EPS is $9.35. During 2025, BIIB reported a per-share earnings of $8.83, which shows a decrease compared to the EPS of $11.21 recorded in 2024. Biogen's EPS for the quarterly period ending on Mar 31, 2026 came in at $2.17.

The yearly earnings per share during 2025 was $8.83, a decrease of 21.2% compared to $11.21 recorded in 2024. Over the quarter ending Mar 31, 2026, the earnings per share came in at $2.17, reflecting a 31.5% increase compared to the same quarter a year earlier. As of March 2026, the TTM EPS is $9.35. During 2024, the annual earnings per share was $11.21, representing an increase of 39.8% compared to 2023.

Over the past 12 months, Biogen has recorded an earnings per share growth rate of 31.5% (YoY, quarterly). Over an extended period, the company recorded an average EPS annual growth rate of -25% per year for the last 3 years. In the last five years, the company had an average annual EPS growth of -18.7%. A ten-year view shows that BIIB has seen an average earnings per share growth of -5.4% per year.